BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31960064)

  • 1. Gene expression profiling of cells of origin of squamous cell carcinomas in head-and-neck, esophagus, and lung.
    Qu N; Huang D; Xu Q; Wang J; Chen C; Ji Q; Wu W; Zhu Y; Xu M
    Acta Biochim Biophys Sin (Shanghai); 2020 Feb; 52(2):211-214. PubMed ID: 31960064
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis.
    Sunpaweravong S; Bunbanjerdsuk S; Pongrujikorn T; Naktang C; Sunpaweravong P; Nitiruangjaras A; Dechaphankul T; Jinawath N
    BMC Cancer; 2019 Dec; 19(1):1174. PubMed ID: 31795956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma.
    Bunbanjerdsuk S; Vorasan N; Saethang T; Pongrujikorn T; Pangpunyakulchai D; Mongkonsiri N; Arsa L; Thokanit N; Pongsapich W; Anekpuritanang T; Ngamphaiboon N; Jinawath A; Sunpaweravong S; Pisitkun T; Suktitipat B; Jinawath N
    Mod Pathol; 2019 Jul; 32(7):943-956. PubMed ID: 30737471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the mir-126, mir-182, and mir-486-5p Expression Signature of Head and Neck Squamous Cell Carcinomas and Lung Squamous Cell Carcinomas.
    Issin G; Kucukodaci Z; Yilmaz I; Erkul E; Tural E; Demirel D; Gungor A; Yildirim S
    Turk Patoloji Derg; 2021; 37(2):106-114. PubMed ID: 33973644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the cells of origin of squamous cell carcinomas.
    Sánchez-Danés A; Blanpain C
    Nat Rev Cancer; 2018 Sep; 18(9):549-561. PubMed ID: 29849070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes.
    Li R; Yang Z; Shao F; Cheng H; Wen Y; Sun S; Guo W; Li Z; Zhang F; Xue L; Bi N; Wang J; Sun Y; Li Y; Tan F; Xue Q; Gao S; Shi S; Gao Y; He J
    Nat Commun; 2021 Jun; 12(1):3785. PubMed ID: 34145257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer.
    Onochi K; Shiga H; Takahashi S; Watanabe N; Fukuda S; Ishioka M; Koizumi S; Matsuhasi T; Jin M; Iijima K
    J Clin Gastroenterol; 2019 Apr; 53(4):e164-e170. PubMed ID: 29498952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
    Katada C; Yokoyama T; Yano T; Kaneko K; Oda I; Shimizu Y; Doyama H; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Konishi K; Yamanouchi T; Tsuda T; Omori T; Kobayashi N; Shimoda T; Ochiai A; Amanuma Y; Ohashi S; Matsuda T; Ishikawa H; Yokoyama A; Muto M
    Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonality of esophageal carcinomas: genetic and epigenetic events leading to loss of genomic stability.
    Jankowski JA
    Dis Esophagus; 1997 Apr; 10(2):143-4. PubMed ID: 9179487
    [No Abstract]   [Full Text] [Related]  

  • 11. TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma.
    Yang Z; Li X; Li J; Su Q; Qiu Y; Zhang Z; Zhang L; Mo W
    Biomed Res Int; 2020; 2020():3962146. PubMed ID: 33083464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
    Kimura S; Naganuma S; Susuki D; Hirono Y; Yamaguchi A; Fujieda S; Sano K; Itoh H
    Oncol Rep; 2010 Jun; 23(6):1625-33. PubMed ID: 20428818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
    World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of GeneChip, nCounter, and Real-Time PCR-Based Gene Expressions Predicting Locoregional Tumor Control after Primary and Postoperative Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
    Schmidt S; Linge A; Grosser M; Lohaus F; Gudziol V; Nowak A; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Schäfer H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Baumann M; Krause M; Löck S;
    J Mol Diagn; 2020 Jun; 22(6):801-810. PubMed ID: 32247864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathological diagnosis of superficial esophageal squamous cell carcinoma and superficial squamous cell carcinoma of head and neck].
    Fujii S; Sunakawa H; Kadota T
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(10):862-867. PubMed ID: 30305567
    [No Abstract]   [Full Text] [Related]  

  • 16. Is high-risk cutaneous squamous cell carcinoma of the head and neck a suitable candidate for current targeted therapies?
    Zilberg C; Lee MW; Kraitsek S; Ashford B; Ranson M; Shannon K; Iyer NG; Ch'ng S; Low TH; Palme C; Clark J; Gupta R; Yu B
    J Clin Pathol; 2020 Jan; 73(1):17-22. PubMed ID: 31300530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances and challenges in aerodigestive epithelial cancer: meeting summary and research opportunities.
    Grandis JR; Carbone DP; Rustgi AK
    Cancer Res; 2007 Aug; 67(16):7556-8. PubMed ID: 17686829
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencing.
    Xue L; Li W; Fan X; Zhao Z; Zhou W; Feng Z; Liu L; Lin H; Li L; Xue X; Huang X; Huang P; Guo J; Du P; Lu N; Li L; Zhan Q; Song Y
    Theranostics; 2020; 10(23):10606-10618. PubMed ID: 32929369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma.
    Prat A; Navarro A; Paré L; Reguart N; Galván P; Pascual T; Martínez A; Nuciforo P; Comerma L; Alos L; Pardo N; Cedrés S; Fan C; Parker JS; Gaba L; Victoria I; Viñolas N; Vivancos A; Arance A; Felip E
    Cancer Res; 2017 Jul; 77(13):3540-3550. PubMed ID: 28487385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.